Several recent studies have reported that the factor V Arg506-->Gln mu
tation is present in 3-10% of adults of European descent. To determine
if the prevalence is comparable among Blacks, we have initiated a cas
e-control study in a large urban hospital in Atlanta which serves a su
bstantial black population. We have evaluated 131 black subjects with
confirmed venous or arterial thrombosis and 61 black subjects without
a history of thrombosis. Only one case and one control were positive f
or the Arg506-->Gln mutation. We conclude that the mutation is more co
mmon among Whites than Blacks.